The COPD and asthma diagnostic & monitoring devices are used for the assessing, diagnosing and treating the patients of lung diseases such as COPD and asthma. As the lung function weakens with age, the respiratory system leads to several physiological, functional & immunological changes. The rising incidence of the chronic lung disease and asthma is pouring the growth of the market. In addition, these devices can be used in hospitals and at home. In addition, air pollution, climate change and allergies continue to drive market growth. Technologically advanced device development, regulatory approvals and product launches are driving market growth.
As per analysis, “COPD and Asthma Diagnostic and Monitoring Devices
Market: Current Analysis and Forecast (2021-2027)” the key
companies operating in the global COPD and asthma diagnostic & monitoring
market include Nihon Kohden Corporation, Vyaire Medical Inc., Getinge AB,
Becton Dickinson And Company, Masimo Corp., Dragerwerk AG & Co. KGAA,
Smiths Medical, Invacare Corporation, Medtronic Plc., Koninklijke Philips N.V
and among others.
In terms of therapeutic devices, COPD and
asthma diagnostic & monitoring market can be segregated as mask, nebulizer,
inhaler, ventilator and PAP (Positive Airway Pressure) device. In terms of
monitoring devices, market can be segregated as capnographs, pulse oximeters
and gas analysis. In terms of diagnostic devices, market can be segregated as
peak flow meters, Polysomnography (PSG) devices, spirometers and other
diagnostic devices. In terms of indication, market can be segregated as COPD
and asthma. The asthma segment holds major share in global market owing to rise
in prevalence of asthma patients. Additionally, in terms of end-user, market
can be segregated as clinics, hospitals, homecare and others. The hospital segment
is likely to exhibit considerable growth rate due to growth in technological
upgradation in COPD & asthma devices during the forecast period.
Based on regional analysis, the North-America
is the leading region in global COPD and
asthma diagnostic & monitoring market owing to rise in prevalence of
respiratory diseases as consequence of unhealthy lifestyles coupled with high
stress levels across the region. The Asia-Pacific and Europe regions are
predicted to witness higher growth rate due to rise in awareness regarding COPD
& asthma devices over the forecast period. It is expected that future of
the global COPD and asthma diagnostic & monitoring market will be
optimistic on account of growth in geriatric population and incorporation of
novel reimbursement models for respiratory & monitoring solution procedures
during the forecast period.
For
More Information, refer to below link:-
Global
COPD and Asthma Diagnostic and Monitoring Market
Contact
Us:-
Ken
Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249
No comments:
Post a Comment